Anti-cancer effects of lutein

Sl.NOType of cancerMechanism of actionReference
1Lung cancer, A549 cell linesInduce apoptosis—PI3K/Akt signaling pathway and ATR/Chk1/p53 signaling pathway
↑Expression of BCL-2 and ↓expression of BAX protein
Suppress expression of SOX2 and NANOG genes in A549
↑Expression of CD44 and CD133, ↓expression of SLCA11 gene
[7981]
2Gastric cancer, AGS cell linesInduce apoptosis—↑DNA fragmentation, caspase-3 activity, the BAX/BCL-2 ratio, and NADPH oxidase-mediated ROS generation[82]
3Hepatic cancer, HepG2 cell linesG2/M phase cell cycle arrest and the phosphorylation of Cdk1 and p53
Alter the phosphorylation of ERK, JNK, and Akt in hyperglycemic cell lines
[83, 84]
4Prostate cancer, PC-3 cell lines↑Drug-induced cell cycle arrest and apoptosis, and also increased the expression of biomarker genes linked to death and proliferation in PC-3 cells[85]

↑: increasing; ↓: decreasing. PI3K: phosphatidylinositol 3-kinase; ROS: reactive oxygen species; ATR: ataxia telangiectasia mutated and Rad3-related kinase; Chk1: checkpoint kinase 1; BCL-2: B-cell lymphoma 2; BAX: BCL-2-associated X protein; SOX2: SRY-related HMG-box protein 2; NANOG: Nanog homeobox; SLCA11: solute carrier family 11 member A1; NADPH: nicotinamide adenine dinucleotide phosphate; ERK: extracellular signal-regulated kinase; AGS: gastric adenocarcinoma; Hep: hepatic; Cdk1: cyclin-dependent kinase 1; JNK: c-Jun N-terminal kinase; Akt: protein kinase B; PC-3: prostate cancer cell line